Roivant Sciences Ltd. (ROIV) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2026 | $5.29B | +2.0% |
| 2025 | $5.19B | -19.6% |
| 2024 | $6.45B | +301.1% |
| 2023 | $1.61B | -21.2% |
| 2022 | $2.04B | -0.0% |
| 2021 | $2.04B | -2.2% |
| 2020 | $2.09B | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2026 | $5.29B | +2.0% |
| 2025 | $5.19B | -19.6% |
| 2024 | $6.45B | +301.1% |
| 2023 | $1.61B | -21.2% |
| 2022 | $2.04B | -0.0% |
| 2021 | $2.04B | -2.2% |
| 2020 | $2.09B | — |